BioTech/Drugs - Beverly, MA, us
Endolytix is developing a novel therapeutics to address the most resistant of antibiotic infections that are difficult to treat, and patient tolerance for current therapies are low.
Outlook
Varnish
Microsoft Office 365
Amazon AWS